Hiroshi Seno Selected Research

Self Expandable Metallic Stents

10/2021	Self-expandable metallic stent placement for malignant biliary stricture using a novel device delivery system.
5/2018	Tumor invasion to the arteries feeding the gallbladder as a novel risk factor for cholecystitis after metallic stent placement in distal malignant biliary obstruction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Seno Research Topics

Disease

61	Neoplasms (Cancer) 03/2024 - 01/2002
14	Hepatocellular Carcinoma (Hepatoma) 07/2022 - 02/2014
10	Inflammation (Inflammations) 01/2023 - 08/2008
10	Infections 01/2023 - 03/2006
10	Carcinogenesis 12/2022 - 01/2004
9	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 03/2006
7	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2004
6	Colitis 03/2024 - 10/2015
6	Ulcerative Colitis 03/2024 - 01/2020
5	Pathologic Constriction (Stenosis) 11/2023 - 04/2019
5	Hemorrhage 01/2023 - 05/2004
4	Neoplasm Metastasis (Metastasis) 04/2023 - 01/2013
4	Adenoma (Adenomas) 01/2023 - 01/2002
4	Rheumatoid Arthritis 01/2023 - 08/2018
4	Pancreatitis 12/2022 - 11/2018
4	Polyps 01/2022 - 01/2002
4	Wounds and Injuries (Trauma) 01/2019 - 01/2009
4	Adenocarcinoma 01/2019 - 01/2002
3	Autoimmune Pancreatitis 01/2024 - 01/2018
3	Crohn Disease (Crohn's Disease) 11/2023 - 04/2005
3	Sclerosing Cholangitis 01/2023 - 12/2017
3	Non-alcoholic Fatty Liver Disease 01/2023 - 02/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 01/2020
3	Necrosis 09/2021 - 05/2012
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 02/2018
3	Colonic Neoplasms (Colon Cancer) 03/2020 - 03/2006
3	Esophageal Squamous Cell Carcinoma 01/2020 - 01/2017
3	Immunoglobulin G4-Related Disease 01/2018 - 01/2016
3	Esophageal and Gastric Varices (Esophageal Varices) 01/2006 - 02/2002
2	Fibrosis (Cirrhosis) 11/2023 - 02/2018
2	Metaplasia 01/2023 - 01/2017
2	Cholangiocarcinoma 01/2023 - 11/2022
2	Hepatitis B 01/2023 - 01/2018
2	Cysts 06/2022 - 11/2018
2	Anorexia 06/2021 - 04/2008
2	Hepatitis 12/2020 - 04/2020
2	Fistula 08/2018 - 04/2005
2	Intestinal Polyps 10/2015 - 01/2002

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
8	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2018
6	Immune Checkpoint InhibitorsIBA 03/2024 - 12/2019
6	CytokinesIBA 01/2023 - 03/2005
5	LigandsIBA 12/2022 - 02/2007
5	nardilysinIBA 01/2019 - 05/2012
4	SteroidsIBA 03/2024 - 01/2018
4	IntegrinsIBA 03/2024 - 01/2021
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 12/2020
4	Antiviral Agents (Antivirals)IBA 01/2023 - 04/2019
4	AntibodiesIBA 01/2023 - 01/2003
4	Messenger RNA (mRNA)IBA 11/2022 - 01/2004
4	EnzymesIBA 07/2022 - 01/2003
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2002
4	lenvatinibIBA 06/2021 - 12/2019
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2011 - 01/2002
3	Calcibiotic Root Canal SealerIBA 03/2024 - 01/2021
3	AutoantibodiesIBA 03/2024 - 01/2021
3	Cadherins (E-Cadherin)IBA 01/2023 - 01/2019
3	Immunoglobulins (Immunoglobulin)IBA 06/2022 - 01/2018
3	Monoclonal AntibodiesIBA 10/2021 - 08/2018
3	Therapeutic UsesIBA 06/2021 - 01/2019
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 11/2023 - 01/2020
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023 - 10/2015
2	Dextrans (Dextran)FDA Link 01/2023 - 10/2015
2	Peptides (Polypeptides)IBA 01/2023 - 03/2006
2	CeruletideIBA 12/2022 - 11/2018
2	Polidocanol (Laureth)FDA Link 06/2022 - 11/2018
2	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2021
2	B7-H1 AntigenIBA 01/2022 - 10/2021
2	VaccinesIBA 01/2022 - 03/2017
2	atezolizumabIBA 01/2022 - 10/2021
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 01/2017
2	DNA Methyltransferase 3BIBA 07/2021 - 12/2020
2	Carrier Proteins (Binding Protein)IBA 06/2021 - 03/2019
2	AutoantigensIBA 01/2021 - 01/2018
2	Tyrosine (L-Tyrosine)FDA Link 12/2020 - 02/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2020 - 01/2014
2	SonazoidIBA 01/2020 - 01/2009
2	Dextran SulfateIBA 10/2019 - 07/2013
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 08/2018
2	Interleukin-13IBA 01/2019 - 01/2009
2	ChemokinesIBA 11/2018 - 01/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 03/2007
2	AzoxymethaneIBA 10/2015 - 07/2013
2	Phenobarbital (Luminal)FDA Link 01/2009 - 01/2003
2	Interleukin-4 (Interleukin 4)IBA 01/2009 - 05/2007
2	Janus Kinase InhibitorsIBA 03/2006 - 06/2004

Therapy/Procedure

29	Therapeutics 01/2024 - 05/2004
7	Stents 12/2023 - 05/2018
7	Drug Therapy (Chemotherapy) 10/2022 - 07/2017
5	Immunotherapy 01/2022 - 03/2020
4	Ligation 01/2006 - 02/2002
3	Sclerotherapy 06/2022 - 01/2006
3	Liver Transplantation 01/2022 - 12/2017
2	Transplantation 01/2023 - 01/2020
2	Aftercare (After-Treatment) 11/2022 - 11/2018
2	Self Expandable Metallic Stents 10/2021 - 05/2018
2	Surgical Instruments (Clip) 11/2020 - 02/2017
2	Catheters 01/2020 - 02/2002